Compare Mounjaro vs Wegovy: The Complete UK Guide
What Is Best Mounjaro or Wegovy: Understanding Key Differences
When determining what is best between Mounjaro or Wegovy for prescription weight loss, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro uses tirzepatide, a dual-action medicine targeting both GIP and GLP-1 receptors, potentially offering enhanced metabolic effects. Both are prescription-only medicines requiring clinical assessment to ensure suitability for your individual health profile and weight management goals.
The question of what is best Mounjaro or Wegovy cannot be answered universally—each treatment offers distinct advantages for different patients. Wegovy benefits from extensive NICE guidance (TA875) and broader NHS availability, whilst Mounjaro's dual-receptor mechanism may appeal to those seeking the newest therapeutic approach. Both treatments require gradual dose escalation over 16 weeks to reach maintenance levels, and both must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber will assess factors including your medical history, current medications, and treatment preferences to recommend the most suitable option.
Wegovy Pricing and Value at EverydayMeds
Our Wegovy pricing structure reflects the treatment's dose escalation schedule, starting with 0.25mg pens at £79.99 for weeks 1-4. The progression continues with 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and maintenance 2.4mg at £209.99 from week 17 onwards. New customers benefit from discount code FIRST40, whilst returning customers use DOSE25, both applied automatically at checkout. Our bundle options provide convenient multi-month supplies, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99.
These prices include clinical assessment, prescriber review, and temperature-controlled next-day delivery once approved. The standard prescriber review takes 3 working days, with express 24-hour review available for urgent requirements. All pricing reflects our GPhC-registered pharmacy assurance (#9012878), ensuring you receive genuine Novo Nordisk Wegovy with full traceability and proper cold-chain storage. Our transparent pricing eliminates hidden fees, with the listed prices representing your final cost after discount codes are applied during the checkout process.
Clinical Evidence: What Is Best Mounjaro or Wegovy Based on Trials
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), compared to 2.4% with placebo. The STEP programme demonstrated consistent results across different populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes and STEP 3 achieving 16% with intensive behavioural therapy. The recent SELECT trial revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's SURMOUNT trials demonstrated significant weight loss outcomes, though direct comparison between trial results isn't appropriate due to different study designs, patient populations, and endpoints. Both treatments showed that weight management requires long-term commitment, with STEP 1 extension data indicating patients regained approximately two-thirds of weight lost within one year of stopping treatment. This emphasises the importance of viewing either medication as part of a comprehensive, ongoing weight management strategy rather than a short-term solution.
How Wegovy Works for Prescription Weight Loss
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This mechanism works on multiple levels to support weight management, primarily by slowing gastric emptying, which helps you feel fuller for longer periods after meals. The medication also acts on appetite centres in your brain, potentially reducing food cravings and the psychological drive to eat. Additionally, Wegovy may influence blood sugar regulation by enhancing insulin sensitivity, though this is secondary to its primary weight management indication. The once-weekly injection schedule using the FlexTouch pen provides consistent medication levels, supporting steady appetite control throughout the week without the need for daily dosing.
Your Wegovy Ordering Process at EverydayMeds
Starting your Wegovy treatment involves a comprehensive yet straightforward 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any contraindications. Once submitted, our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring clinical appropriateness before approving your prescription. Upon approval, your Wegovy pen is dispatched via next-day delivery using specialist cold-chain transport to maintain the required 2-8°C temperature throughout transit. Each delivery includes detailed injection instructions, dose escalation guidance, and direct contact details for ongoing clinical support. Our GPhC-registered pharmacy (#9012878) ensures full medication traceability and pharmaceutical oversight throughout your treatment journey.
Storage and Practical Considerations
Wegovy offers significant practical advantages in terms of storage flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules who may not have consistent refrigerator access. The FlexTouch pen system provides precise, user-friendly injection with dose escalation clearly marked on each pen—starting with 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, 1.7mg, and reaching maintenance 2.4mg from week 17 onwards. Each pen contains four weekly doses, and the dose escalation schedule cannot be accelerated, ensuring optimal tolerance and effectiveness. Unused pens should be stored in the refrigerator at 2-8°C, and each pen includes safety features to prevent accidental injection and ensure accurate dosing.
Comparing Dual-Action vs Single-Action Weight Loss Mechanisms
Understanding what is best between Mounjaro or Wegovy requires appreciating their distinct pharmacological approaches to weight management. Wegovy's single-action GLP-1 receptor targeting provides proven, well-established appetite suppression and metabolic benefits, supported by extensive clinical evidence and NICE recommendations. The medication's focused mechanism offers predictable effects with well-documented side effect profiles, making it suitable for most patients seeking prescription weight loss support.
Mounjaro's dual-action approach targeting both GIP and GLP-1 receptors represents a newer therapeutic strategy that may offer enhanced metabolic effects for certain patients. However, both treatments require identical lifestyle modifications—reduced-calorie diet and increased physical activity—and both involve similar injection schedules and dose escalation protocols. The choice between single-action and dual-action mechanisms often depends on individual response patterns, previous treatment experiences, and specific metabolic considerations that your prescriber will evaluate during clinical assessment.
Start Your Wegovy Treatment Today
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your weight management goals and medical profile. Our streamlined ordering process, competitive pricing from £79.99, and expert clinical oversight ensure you receive the most appropriate treatment with comprehensive support. Use discount code FIRST40 for new customers or DOSE25 for returning patients, both applied automatically at checkout to provide immediate value. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards medically-supervised weight management. Our UK-registered pharmacy (GPhC #9012878) ensures authentic medication, professional oversight, and ongoing support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
